
Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial
Author(s) -
Jane Kabami,
Laura B. Balzer,
Hachem Saddiki,
James Ayieko,
Dalsone Kwarisiima,
Mucunguzi Atukunda,
Edwin D. Charlebois,
Tamara D. Clark,
Catherine A. Koss,
Theodore Ruel,
Elizabeth A. Bukusi,
Craig R. Cohen,
Phillipa Musoke,
Maya Petersen,
Diane V. Havlir,
Moses R. Kamya,
Gabriel Chamie
Publication year - 2020
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002564
Subject(s) - medicine , viral load , pregnancy , population , randomized controlled trial , obstetrics , postpartum period , immunology , human immunodeficiency virus (hiv) , environmental health , biology , genetics
We sought to determine whether universal 'test and treat' (UTT) can achieve gains in viral suppression beyond universal antiretroviral treatment (ART) eligibility during pregnancy and postpartum, among women living with HIV.